Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking and Finance Review

Global Banking & Finance Review

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2025 GBAF Publications Ltd - All Rights Reserved.

    Editorial & Advertiser disclosure

    Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Headlines > EU, WHO counter Trump's warnings on autism and pregnancy
    Headlines

    EU, WHO counter Trump's warnings on autism and pregnancy

    EU, WHO counter Trump's warnings on autism and pregnancy

    Published by Global Banking and Finance Review

    Posted on September 23, 2025

    Featured image for article about Headlines

    LONDON/GENEVA (Reuters) -European Union and British health agencies confirmed the safety of paracetamol during pregnancy, disputing a warning from U.S. President Donald Trump linking the popular pain medication to autism.

    The World Health Organization said on Tuesday that evidence of a link remained inconsistent and urged caution in drawing conclusions.

    Trump had on Monday linked autism to childhood vaccine use and the taking of Tylenol by women when pregnant, elevating claims not backed by scientific evidence to the forefront of U.S. health policy.

    The European Medicines Agency said on Tuesday that there was no new evidence that would require changes to the region's current recommendations for the use of paracetamol, known as Tylenol in the United States, during pregnancy.

    "Available evidence has found no link between the use of paracetamol during pregnancy and autism," the EMA said in a statement, adding paracetamol could be used during pregnancy when needed, though at the lowest effective dose and frequency. On Monday, Britain's health regulator said that it was safe to use.

    "The evidence remains inconsistent," WHO spokesperson Tarik Jašarević told a Geneva press briefing when asked about a possible link between paracetamol use in pregnancy and autism.

    He cited unspecified studies that pointed to a possible link but said that this was not confirmed by subsequent research. "This lack of replicability really calls for caution in drawing casual conclusions," he said.

    In a highly unusual press conference at the White House on Monday, Trump delivered medical advice to pregnant women and parents of young children, repeatedly telling them not to use or administer the painkiller and suggesting that common vaccines not be taken together or so early in a child's life.

    The advice from Trump goes against that of medical societies, which have cited data from numerous studies showing that acetaminophen, the active ingredient in Tylenol, plays a safe role in the well-being of pregnant women.

    Asked to elaborate further on Trump's remarks, Jašarević added that vaccines did not cause autism and affirmed their life-saving qualities. "This is something that science has proven, and these things should not be really questioned," he added.

    (Reporting by Maggie Fick and Emma Farge; Writing by Adam Jourdan; Editing by Alex Richardson)

    Related Posts
    Novartis, Roche back US efforts to lower drug costs amid talk of pricing deal
    Novartis, Roche back US efforts to lower drug costs amid talk of pricing deal
    Saudi, French and U.S. officials push Hezbollah disarmament plan
    Saudi, French and U.S. officials push Hezbollah disarmament plan
    Russia sentences Briton who it says fought for Ukraine to 13 years in a prison camp
    Russia sentences Briton who it says fought for Ukraine to 13 years in a prison camp
    Ukrainian negotiators to meet US team on Friday, Saturday, Zelenskiy says
    Ukrainian negotiators to meet US team on Friday, Saturday, Zelenskiy says
    Court hearing adjourned in strangulation case involving UK's Duke of Marlborough
    Court hearing adjourned in strangulation case involving UK's Duke of Marlborough
    Ukraine says 180,000 consumers were left without power after Russian overnight attack
    Ukraine says 180,000 consumers were left without power after Russian overnight attack
    China says it is granting new, streamlined rare earth export licences
    China says it is granting new, streamlined rare earth export licences
    Romania to raise minimum wage by 6.8% from July
    Romania to raise minimum wage by 6.8% from July
    Coinbase appoints UK ex-finance minister George Osborne to run advisory council
    Coinbase appoints UK ex-finance minister George Osborne to run advisory council
    EU must reform or risk irrelevance, Blair and Dimon say
    EU must reform or risk irrelevance, Blair and Dimon say
    Russian attack on Ukraine's central Cherkasy injures six, causes blackouts, governor says
    Russian attack on Ukraine's central Cherkasy injures six, causes blackouts, governor says
    Europe's auto industry future may be electric even after EU climbdown
    Europe's auto industry future may be electric even after EU climbdown

    Why waste money on news and opinions when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    More from Headlines

    Explore more articles in the Headlines category

    Factbox-Can Ukraine survive without the EU's 'reparation loan'?

    Factbox-Can Ukraine survive without the EU's 'reparation loan'?

    EU leaders face crunch decision on using frozen Russian assets for Ukraine

    EU leaders face crunch decision on using frozen Russian assets for Ukraine

    Analysis-Return of 'Make Europe Great Again' trades hinges on German comeback

    Analysis-Return of 'Make Europe Great Again' trades hinges on German comeback

    Belarus' Lukashenko says US admission of failure to overturn re-election could revive relations

    Belarus' Lukashenko says US admission of failure to overturn re-election could revive relations

    Ukrainian drones kill three people in Russia's Rostov region, authorities say

    Ukrainian drones kill three people in Russia's Rostov region, authorities say

    Shares in South Korea's LGES drop more than 7% after Ford cancels EV battery deal

    Shares in South Korea's LGES drop more than 7% after Ford cancels EV battery deal

    Factbox-What we know about the shooting victims at Sydney's Bondi Beach Jewish event

    Factbox-What we know about the shooting victims at Sydney's Bondi Beach Jewish event

    Australia promises new hate laws as youngest Bondi Beach shooting victim is laid to rest

    Australia promises new hate laws as youngest Bondi Beach shooting victim is laid to rest

    UN, aid groups warn Gaza operations at risk from Israel impediments

    UN, aid groups warn Gaza operations at risk from Israel impediments

    IMF says Moldova's economy has unique growth opportunity, but reforms needed

    IMF says Moldova's economy has unique growth opportunity, but reforms needed

    UK firm Awendio Solaris plans $725 million solar plant with indigenous groups in Canada

    UK firm Awendio Solaris plans $725 million solar plant with indigenous groups in Canada

    AbbVie, several other pharma companies near MFN deal with Trump, sources say

    AbbVie, several other pharma companies near MFN deal with Trump, sources say

    View All Headlines Posts
    Previous Headlines PostEU to delay anti-deforestation law by another year
    Next Headlines PostConvicted rapist loses European court case over right to vote in UK election